Credit Suisse’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.25M | Sell |
|
|||||
|
2023
Q4 | $1.17M | Sell |
|
|||||
|
2023
Q3 | $1.15M | Sell |
|
|||||
|
2023
Q2 | $1.77M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Buy |
|
|||||
|
2022
Q4 | $636K | Buy |
|
|||||
|
2022
Q3 | $490K | Buy |
|
|||||
|
2022
Q2 | $390K | Sell |
|
|||||
|
2022
Q1 | $692K | Sell |
|
|||||
|
2021
Q4 | $963K | Buy |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $398K | Sell |
|
|||||
|
2021
Q1 | $607K | Sell |
|
|||||
|
2020
Q4 | $2.15M | Sell |
|
|||||
|
2020
Q3 | $3.24M | Buy |
|
|||||
|
2020
Q2 | $757K | Sell |
|
|||||
|
2020
Q1 | $263K | Sell |
|
|||||
|
2019
Q4 | $641K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $29K | Sell |
|
|||||
|
2016
Q3 | $207K | Buy |
|
|||||
|
2016
Q2 | $270K | Buy |
|
|||||
|
2016
Q1 | $225K | Buy |
|
|||||
|
2015
Q4 | $275K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $850K | Buy |
|
|||||
|
2014
Q2 | $226K | Buy |
|
|||||
|
2014
Q1 | $209K | Buy |
|